China Opens Patent Linkage Registration Public Testing Platform
Thursday, May 20, 2021 On May 18, 2021, the Center for Drug Evaluation of China’s National Medical Products Administration has issued the “Notice on the public testing of the patent information registration platform related to the early settlement mechanism of drug patent disputes and other related matters” (关于药品专利纠纷早期解决机制相关专利信息登记平台公开测试等有关事宜的通知) opening up China’s patent linkage registration platform (similar to the FDA’s orange book) for testing through May 31, 2021. The registration system is ava...
Source: natlawreview.com